Increasing clinician participation in tobacco cessation by an implementation science-based tobacco cessation champion program.
Cancer Center Cessation Initiative
Certified tobacco treatment specialists
Tobacco cessation
Journal
Cancer causes & control : CCC
ISSN: 1573-7225
Titre abrégé: Cancer Causes Control
Pays: Netherlands
ID NLM: 9100846
Informations de publication
Date de publication:
Jan 2023
Jan 2023
Historique:
received:
02
03
2022
accepted:
08
08
2022
pubmed:
13
10
2022
medline:
10
1
2023
entrez:
12
10
2022
Statut:
ppublish
Résumé
We designed a process to increase tobacco cessation in an academic center and its widely distributed network community sites using clinical champions to overcome referral barriers. In 2020 a needs assessment was performed across the City of Hope Medical Center and its 32 community treatment sites. We reviewed information science strategies to choose elements for our expanded tobacco control plan, focusing on distributed leadership with tobacco cessation champions. We analyzed smoking patterns in patients with cancer before and following program implementation. We evaluated the champion experience and measured tobacco abstinence after 6 months of follow-up. Cancer center leadership committed to expanding tobacco control. Funding was obtained through a Cancer Center Cessation Initiative (C3I) grant. Multi-disciplinary leaders developed a comprehensive plan. Disease-focused clinics and community sites named cessation champions (a clinician and nurse) supported by certified tobacco treatment specialists. Patient, staff, clinician, and champion training/education were developed. Roles and responsibilities of the champions were defined. Implementation in pilot sites showed increased tobacco assessment from 80.8 to 96.6%, increased tobacco cessation referral by 367%, and moderate smoking abstinence in both academic (27.2%) and community sites (22.5%). 73% of champions had positive attitudes toward the program. An efficient process to expand smoking cessation in the City of Hope network was developed using implementation science strategies and cessation champions. This well-detailed implementation process may be helpful to other cancer centers, particularly those with a tertiary care cancer center and community network.
Sections du résumé
BACKGROUND
BACKGROUND
We designed a process to increase tobacco cessation in an academic center and its widely distributed network community sites using clinical champions to overcome referral barriers.
METHODS
METHODS
In 2020 a needs assessment was performed across the City of Hope Medical Center and its 32 community treatment sites. We reviewed information science strategies to choose elements for our expanded tobacco control plan, focusing on distributed leadership with tobacco cessation champions. We analyzed smoking patterns in patients with cancer before and following program implementation. We evaluated the champion experience and measured tobacco abstinence after 6 months of follow-up.
RESULTS
RESULTS
Cancer center leadership committed to expanding tobacco control. Funding was obtained through a Cancer Center Cessation Initiative (C3I) grant. Multi-disciplinary leaders developed a comprehensive plan. Disease-focused clinics and community sites named cessation champions (a clinician and nurse) supported by certified tobacco treatment specialists. Patient, staff, clinician, and champion training/education were developed. Roles and responsibilities of the champions were defined. Implementation in pilot sites showed increased tobacco assessment from 80.8 to 96.6%, increased tobacco cessation referral by 367%, and moderate smoking abstinence in both academic (27.2%) and community sites (22.5%). 73% of champions had positive attitudes toward the program.
CONCLUSION
CONCLUSIONS
An efficient process to expand smoking cessation in the City of Hope network was developed using implementation science strategies and cessation champions. This well-detailed implementation process may be helpful to other cancer centers, particularly those with a tertiary care cancer center and community network.
Identifiants
pubmed: 36224501
doi: 10.1007/s10552-022-01619-1
pii: 10.1007/s10552-022-01619-1
pmc: PMC9555700
doi:
Types de publication
Review
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
81-88Subventions
Organisme : NCI NIH HHS
ID : P30 CA033572
Pays : United States
Organisme : NIH HHS
ID : P30 CA033572
Pays : United States
Organisme : NIH HHS
ID : P30 CA033572-37S5
Pays : United States
Informations de copyright
© 2022. The Author(s), under exclusive licence to Springer Nature Switzerland AG.
Références
Healthc Q. 2009;12 Spec No Patient:123-8
pubmed: 19667789
Patient Educ Couns. 2012 Mar;86(3):414-9
pubmed: 21784598
JAMA. 2021 Jan 19;325(3):280-298
pubmed: 33464342
Implement Sci. 2015 Aug 07;10:109
pubmed: 26249843
NPJ Prim Care Respir Med. 2017 Jun 23;27(1):41
pubmed: 28646217
Implement Sci. 2009 Aug 07;4:50
pubmed: 19664226
N Engl J Med. 2020 Oct 22;383(17):1606-1609
pubmed: 33085859
JAMA. 2021 Jan 19;325(3):265-279
pubmed: 33464343
SAGE Open Med. 2018 May 17;6:2050312118773261
pubmed: 29796266
Nicotine Tob Res. 2007 Mar;9(3):341-9
pubmed: 17365766
Front Public Health. 2020 Jun 12;8:221
pubmed: 32596200
Ann Thorac Surg. 2014 Sep;98(3):996-1002
pubmed: 25063304
Implement Sci. 2015 Feb 12;10:21
pubmed: 25889199
Transl Lung Cancer Res. 2019 May;8(Suppl 1):S59-S66
pubmed: 31211106
Oncology. 2018;95(3):129-137
pubmed: 29920482
J Clin Med. 2020 Jun 11;9(6):
pubmed: 32545244
BMC Cancer. 2017 May 19;17(1):348
pubmed: 28526000
Am J Prev Med. 2008 Aug;35(2):158-76
pubmed: 18617085
Transl Lung Cancer Res. 2019 May;8(Suppl 1):S50-S58
pubmed: 31211105